Zhejiang Benli Technology Co. Ltd. (301065) - Total Liabilities

Latest as of June 2025: CN¥317.03 Million CNY ≈ $46.39 Million USD

Based on the latest financial reports, Zhejiang Benli Technology Co. Ltd. (301065) has total liabilities worth CN¥317.03 Million CNY (≈ $46.39 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 301065 cash flow conversion to assess how effectively this company generates cash.

Zhejiang Benli Technology Co. Ltd. - Total Liabilities Trend (2019–2024)

This chart illustrates how Zhejiang Benli Technology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check 301065 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Zhejiang Benli Technology Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Zhejiang Benli Technology Co. Ltd. ranked by their total liabilities.

Company Country Total Liabilities
Talgo SA
MC:TLGO
Spain €1.28 Billion
HAXC Holdings (Beijing) Co. Ltd.
SHE:300928
China CN¥186.17 Million
Dalian Friendship Group Co Ltd
SHE:000679
China CN¥864.17 Million
Kretam Holdings Bhd
KLSE:1996
Malaysia RM239.88 Million
ACOTEC SCIEN.H. DL-00001
F:7W3
Germany €384.00 Million
Jiangsu Feiliks Intl Logistics
SHE:300240
China CN¥2.33 Billion
goeasy Ltd
TO:GSY
Canada CA$4.97 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Zhejiang Benli Technology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Benli Technology Co. Ltd. (301065) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.83 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.24 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.19 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Benli Technology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Benli Technology Co. Ltd. (2019–2024)

The table below shows the annual total liabilities of Zhejiang Benli Technology Co. Ltd. from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥317.36 Million
≈ $46.44 Million
+62.66%
2023-12-31 CN¥195.10 Million
≈ $28.55 Million
+32.24%
2022-12-31 CN¥147.54 Million
≈ $21.59 Million
+1.83%
2021-12-31 CN¥144.89 Million
≈ $21.20 Million
-13.57%
2020-12-31 CN¥167.63 Million
≈ $24.53 Million
+5.78%
2019-12-31 CN¥158.47 Million
≈ $23.19 Million
--

About Zhejiang Benli Technology Co. Ltd.

SHE:301065 China Chemicals
Market Cap
$377.46 Million
CN¥2.58 Billion CNY
Market Cap Rank
#13945 Global
#4388 in China
Share Price
CN¥24.33
Change (1 day)
-0.65%
52-Week Range
CN¥20.64 - CN¥25.99
All Time High
CN¥51.11
About

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hy… Read more